Research / Publications

  1. 338. Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System. Kesavadev J, Basanth A, Krishnan G, Shankar A, Sanal G, Jothydev S. Diabetes Therapy. 2023 Jun 6:1-2. Read More
  2. 337. Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring. Kesavadev, J., Mohan, V. J Indian Inst Sci. 2023 Apr 2023. Read More
  3. 336. Human Digital Twin for Personalized Elderly Type 2 Diabetes Management. Thamotharan P, Srinivasan S, Kesavadev J, Krishnan G, Mohan V, Seshadhri S, Bekiroglu K, Toffanin C. Journal of Clinical Medicine. 2023 Mar 7;12(6):2094. Read More
  4. 335. Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades. Saboo B, Chandalia H, Ghosh S, Kesavadev J, Kochar I, Prasannakumar KM, Sarda A, Bantwal G, Mehrotra RN, Rai M. Current Diabetes Reviews. 2023 Mar 10. | Request Full-text
  5. 334. Intermittent Use of Continuous Glucose Monitoring: A New Paradigm in Treatment of Type 2 Diabetes. Saboo B, Unnikrishnan R, Kesavadev J, Tiwaskar M, Czupryniak L, Chawla M, Choudhary P, Battelino T, Agarwal S, Danne T, Mohan V. J Assoc Physicians India 2023;71(6):51–56. | Request Full-text
  6. 333. Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades. Saboo B, Chandalia H, Ghosh S, Kesavadev J, Kochar I, Prasannakumar KM, Sarda A, Bantwal G, Mehrotra RN, Rai M. Current Diabetes Reviews. 2023 Mar 10.
  7. 332. Comparing the benefits of applying a vacuum-assisted lancing device in reducing lancing pain, improving self-monitoring frequency, and reducing HbA1c in people with diabetes. Kesavadev J, Chandran GB, Basanth A, Krishnan G, Shankar A, Jothydev S. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2023 Mar 2:102731. | Request Full-text
  8. 331. Effects of Customised Structured SMBG on Glycemic Control in People with Diabetes over 10 Years. Kesavadev J, Shankar A, Jothydev K, Krishnan G, B. Saboo, Joshi S, Sanal G, Rajalekshmi S, Basanth A, Jothydev S. Advanced Technologies & Treatments for Diabetes, 16th International Conference, Berlin and Online, February 22–25, 2023. e-poster presentation. Read More
  9. 330. Assessing TIR Metrics and A1C in PwD and its Association with Treatment Related Variables. Kesavadev J, Shankar A, Krishnan G, Saboo B, Joshi S, Chawla M, Basanth A, Jothydev S. Advanced Technologies & Treatments for Diabetes, 16th International Conference, Berlin and Online, February 22–25, 2023. Oral Presentation. Read More
  10. 329. Do-it-yourself Artificial Pancreas: The Affordable Indian Experience. Kesavadev J. Advanced Technologies & Treatments for Diabetes, 16th International Conference, Berlin and Online, February 22–25, 2023. Invited Speaker Read More
  11. 328. Long-term Impact of Telehealth (Diabetes Tele Management System®) Intervention on Treatment Satisfaction, Quality of Life, and Clinical Outcomes in People with Type 2 Diabetes: A 15-year Retrospective Cohort Study. Jothydev, Krishnadev; Basanth, Anjana; Chandran, Gopika Beena; Shankar, Arun; Krishnan, Gopika; Sanal, Geethu; Lally, Jayasree; Sreelakshmi, R.; Jothydev, Sunitha; Kesavadev, Jothydev. International Journal of Diabetes and Technology 2(1):p 22-30, Jan–Mar 2023. | DOI: 10.4103/ijdt.ijdt_25_23 Read More
  12. 327. Advancements in Insulin Delivery Technology: A Journey of Evolution. Joshi, Shashank R.; Kesavadev, Jothydev1; Saboo, Banshi2; Parikh, Rakesh3; Chawla, Manoj4; Gupta, Amit4; Bhartia, Mithun5; Shankar, Arun1; Basanth, Anjana1; Krishnan, Gopika1. International Journal of Diabetes and Technology 2(1):p 7-15, Jan–Mar 2023. | DOI: 10.4103/ijdt.ijdt_24_23 Read More
  13. 326. Continuous Glucose Monitoring in Non-Insulin Type 2 Diabetes. Kesavadev, Jothydev; Saboo, Banshi1; Makkar, Brij Mohan2; Agarwal, Sanjay3; Chawla, Manoj4; Chandran, Vysakh; Shankar, Arun; Basanth, Anjana. International Journal of Diabetes and Technology 2(1):p 16-21, Jan–Mar 2023. | DOI: 10.4103/ijdt.ijdt_26_23 Read More
  14. 325. Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective. Mohan V, Joshi S, Mithal A, Kesavadev J, Unnikrishnan AG, Saboo B, Kumar P, Chawla M, Bhograj A, Kovil R. Diabetes Ther. Jan 2023. doi: 10.1007/s13300-022-01355-4. PMID: 36705888. | Request Full-text
  15. 324. Fibroscan as an easy-to-use tool in predicting NAFLD progression in diabetes Shankar A, Kesavadev J, Krishnan G, Jose R, Basanth A, Jothydev S. IDF World Diabetes Congress 2022, Lisbon and online. Dec 5-8, 2022. e-poster
  16. 323. Merits And Demerits Of Using Telemedicine Based Program For Diabetes Management. Kesavadev J, Saboo B, Jothydev K, Shankar A, Krishnan G, Lally J, Sanal G, Rajalakshmi S, Jothydev S. IDF World Diabetes Congress 2022, Lisbon and online. Dec 5-8, 2022. e-poster
  17. 322. User Perception And Satisfaction With An Advanced Hybrid Closed Loop System: The Experience From Kerala. Krishnan G, Kesavadev J, Shankar A, Unes Y, Ashik A, Sanal G, Krishna V, Rajalakshmi S, Basanth A, Jothydev S. IDF World Diabetes Congress 2022, Lisbon and online. Dec 5-8, 2022. e-poster
  18. 321. Points In Range As An Alternative To Time In Range In Resource-Limited Settings. Kesavadev J, Saboo B, Joshi S R, Shankar A, Krishnan G, Sanal G, Lally J, Basanth A, Jothydev S. IDF World Diabetes Congress 2022, Lisbon and online. Dec 5-8, 2022. e-poster Read More
  19. 320. A Reliable Risk Score For ASCVD In Indian Type 2 Diabetes. Ashik A, Johnson J, Kesavadev J, Shankar A, Krishnan G, Basanth A, Jothydev S. IDF World Diabetes Congress 2022, Lisbon and online. Dec 5-8, 2022. e-poster Read More
  20. 319. Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India. Kalra S, Unnikrishnan AG, Prasanna Kumar KM, Sahay R, Chandalia HB, Saboo B, Annamalai S, Kesavadev J, Shukla R, Wangnoo SK, Baruah MP. Diabetes Therapy. 2022 Nov 15:1-7. Link 1 | Link 2
  21. 318. Comparing points in target range assessed by Blood Glucose Monitoring (BGM) using a vacuum-based lancing device and a conventional lancing device. Kesavadev. J, Beena Chandran G, Krishnan G, Basanth A, Shankar A, Jothydev S. Poster presentation. ISPAD 48th Annual Conference. United Arab Emirates. 13-16 Oct 2022 Read More
  22. 317. Health care delivery model in India with relevance to diabetes care. Das AK, Saboo B, Maheswari A, Banerjee S, Jayakumar C, Mohan AR, Potty VS, Kesavadev J. Heliyon. 2022 Oct 4:e10904. Read More
  23. 316. Sodium-glucose Cotransporter-2 Inhibitors in Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus: A Meta-analysis. Kovil R, Chawla M, Shah T, Sahoo A, Makkar B, Kesavadev J, Seshadri K, Tiwaskar M, Rajput R, Phatak S, Majumdar S. The Journal of the Association of Physicians of India. 2022 Aug 1;70(8):11-2.
  24. 315. Insulin Degludec/Insulin Aspart (IDegAsp) safely improves HbA1c: a long-term real-world cohort study (IDEA). Kesavadev J, Saboo B, Kovil R, Joshi S, Shankar A, Ashik A, Ashok AD, Basanth A, Krishnan G. Diabetes, Obesity and Metabolism. 2022 Aug 20. Read More
  25. 314. Scientific advisory on nocturnal hypoglycemia in insulin-treated patients with diabetes: Recommendations from Indian experts. Chawla M, Chawla P, Saboo B, Chawla R, Gangopadhyay KK, Kalra S, Aravind S, Sinha BC, Shah T, Kesavadev J, Rajput R. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2022 Aug 23:102587.
  26. 313. Comparing Points in Target Range Assessed by Blood Glucose Monitoring Using a Vacuum-based Lancing Device and Conventional Lancing Devices. Kesavadev, Jothydev; Shankar, Arun; Basanth, Anjana; Krishnan, G. Gopika; Sreelaksmi, R.; Gopika, Beena Chandran; Jothydev, Sunitha. International Journal of Diabetes and Technology 1(3):p 111-113, Jul–Sep 2022. | DOI: 10.4103/ijdt.ijdt_10_23 Read More
  27. 312. History, Classification, and Clinical Utility of Connected Insulin Pens. Kesavadev, Jothydev; Saboo, Banshi1; Parikh, Rakesh2; Gupta, Amit3; Krishnan, Gopika; Bhartia, Mithun4; Salis, Sheryl5; Joshi, Shashank6. International Journal of Diabetes and Technology 1(3):p 104-110, Jul–Sep 2022. | DOI: 10.4103/ijdt.ijdt_11_23 Read More
  28. 311. Managing Coronavirus Disease – Success Stories from Kerala Kesavadev, Jothydev; Raj, Sumesh1; Shiji, P. V.; Kumar, B. Padma3; Raveendran, Arkiath Veettil4; Moses, Bobby5; Pillai, Anand Marthanda6; Prasobh, Sunil7; Ashik, Asha; Krishnan, Gopika; Basanth, Anjana. International Journal of Diabetes and Technology 1(3):p 89-96, Jul–Sep 2022. | DOI: 10.4103/ijdt.ijdt_3_23 Read More
  29. 310. The role of oral semaglutide in managing type 2 diabetes in Indian clinical settings: Addressing the unmet needs. Joshi, S.R., Rajput, R., Chowdhury, S., Singh, A.K., Bantwal, G., Das, A.K., Unnikrishnan, A.G., Saboo, B.D., Kesavadev, J., Ghosal, S. and Mohan, V. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16(6), June 2022, p.102508. Read More
  30. 309. Empowering Patients with Type 1 Diabetes Through a Multidisciplinary Team-assisted, Technology-Enabled Education Program. Sanal G, Shijin S, Krishna V, Kesavadev J, Basanth A, Krishnan G, Shankar A. Curr Diabetes Rev. 2022 May 20. doi: 10.2174/1573399818666220520115420.
  31. 308. WhatsApp Support Group for 950 Children and Adolescents/Parents with Type 1 Diabetes - Physician’s Perspective on Merits and Demerits. Kesavadev J. Advanced Technologies & Treatments for Diabetes, 15th International Conference, Barcelona, April 2022. Invited Speaker Read More
  32. 307. Comparing the Benefits of a Painless Lancing Device in People with Diabetes in Improving Self-Monitoring Frequency and HbA1c. Kesavadev J, Beena Chandran G, Basanth A, Krishnan G, Shankar A. Advanced Technologies & Treatments for Diabetes, 15th International Conference, Barcelona, April 2022. Oral Presentation. Read More
  33. 306. Can Physical Activity as an Independent Parameter Influence TIR?. Kesavadev J, Shankar A, Krishnan G, Sanal G, Basanth A. Advanced Technologies & Treatments for Diabetes, 15th International Conference, Barcelona, April 2022. Oral Presentation Read More
  34. 305. One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study). Kesavadev J, Murthy LS, Chaudhury T, Yalamanchi SR, Giri J, Gupta S, Phatak S, Modi KD, Chatterjee S, Manjunath A, Revanna M. Metabolism Open. 2022 Apr 18:100184. Read More | Request Full-text
  35. 304. Time below Range: Retrospective Continuous Glucose Monitoring Analysis to Detect Hypoglycemia in Routine Clinical Practice. Chawla, Manoj; Chawla, Purvi; Saboo, Banshi1; Kesavadev, Jothydev2; Gupta, Amit3; Parikh, Rakesh4. International Journal of Diabetes and Technology 1(2):p 69-74, Apr–Jun 2022. | DOI: 10.4103/ijdt.ijdt_12_22 Read More
  36. 303. Demystifying the Progression of Retinopathy with Glucagon-Like Peptide-1 Receptor Agonists: Facts, Evidence, and Misperceptions. Kesavadev, Jothydev; Unnikrishnan, A. G.1,; Sanyal, Debmalya2; Aneja, Pankaj3; Saboo, Banshi D.4. International Journal of Diabetes and Technology 1(2):p 53-55, Apr–Jun 2022. | DOI: 10.4103/ijdt.ijdt_17_22 Read More
  37. 302. Diabetic ketoacidosis in COVID new-onset patients. Saboo, B., Mehta, J., Ghosh, S., Kesavadev, J. Critical Care Update 2022, 4, March 2022, p. 761-766 Read More
  38. 301. The Severity of Breakthrough Infections Post-COVID-19 Vaccination in Healthcare and Public Sector in South India. Kesavadev, Jothydev; Manojan, K. K.1; Benny, P. V.2; Raj, Sumesh1; Shankar, Arun; Krishnan, Gopika; Basanth, Anjana; Jothydev, Sunitha. International Journal of Diabetes and Technology 1(1):p 46-50, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_6_22 Read More
  39. 300. The Significance of Repeated Education in Correcting Insulin Injection Techniques and Improving Glycemic Control. Krishnan, Gopika; Kesavadev, Jothydev; Benny, Nelena; Basanth, Anjana; Joshi, Shashank R.1; Gupta, Sunil2. International Journal of Diabetes and Technology 1(1):p 42-45, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_8_22 Read More
  40. 299. Positioning “Time-in-Range” in the Treatment of Diabetes in India. Mohan, Viswanathan; Unnikrishnan, Ambika G.1; Kesavadev, Jothydev2; Saboo, Banshi3. International Journal of Diabetes and Technology 1(1):p 32-41, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_2_22 Read More
  41. 298. One Hundred and One Years of Insulin Delivery with Transition from Syringes to User-Friendly Technologies. Kesavadev, Jothydev; Saboo, Banshi; Benny, Nelena; Basanth, Anjana; Krishnan, Gopika; Shankar, Arun; Jothydev, Sunitha. International Journal of Diabetes and Technology 1(1):p 25-31, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_5_22 Read More
  42. 297. How Can Diabetes Technologies Reduce the Burden of Cost?. Kesavadev, Jothydev; Sreelakshmi. R; Krishnan, Gopika; Basanth, Anjana; Jothydev, Sunitha; Saboo, Banshi. International Journal of Diabetes and Technology 1(1):p 13-19, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_7_22 Read More
  43. 296. Quackery in Diabetes – Time to Act. Ashik, Asha; Basanth, Anjana, Benny, PV, Kesavadev, Jothydev. International Journal of Diabetes and Technology 1(1):p 8-12, Jan–Mar 2022. | DOI: 10.4103/ijdt.ijdt_4_22 Read More
  44. 295. Prescribing Patterns and Response to Antihyperglycemic Agents Among Novel Clusters of Type 2 Diabetes in Asian Indians. Anjana RM, Siddiqui MK, Jebarani S, Vignesh MA, Kamal Raj N, Unnikrishnan R, Pradeepa R, Panikar VK, Kesavadev J, Saboo B, Gupta S. Diabetes technology & therapeutics. 2022 Jan 5. Read More | Request Full-text
  45. 294. Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with Ryzodeg™ Treatment). Kesavadev J, Gowda A, Kumar H, Yalamanchi SR, Lodha S, Singh KP, Basu D, Asirvatham A, Shah N, Pathan MK, Revanna M. Medical Sciences. 2021 Dec 21;10(1):1. Link 1 | Link 2
  46. 293. Type 2 Diabetes in Women-Different and Difficult. Kesavadev, J., Abraham, G., Chandni, R., Chawla, P., Nambiar, A., Deshpande, N., Joshi, S., Jothydev, S., Krishnan, G. and Das, A.K. Current diabetes reviews. 7 Dec 2021. Read More
  47. 292. Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia. Kesavadev J, Misra A, Saboo B, Agarwal S, Sosale A, Joshi S R, Hussain A, Somasundaram N, Basit A, Choudhary P, Soegondol S. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Nov 2021, 102345. Read More
  48. 291. Role of a multidisciplinary team assisted, technology-enabled education program in empowering people with type 1 diabetes. Kesavadev J, Saboo B, Shijin S, Shankar A, Unes Y, Sanal G, Krishna V, Basanth A, R S, Beena Chandran G, Krishnan G, Jothydev S. e-poster presentation. ISPAD 2021 Abstract Book. ISPAD 47th Annual Conference, Virtual. Oct 2021. pp 113; eP148 Read More
  49. 290. Screening for Diabetes in India Should be Initiated at 25 Years Age. Misra A, Ramachandran A, Saboo B, Kesavadev J, Sosale A, Joshi S, Kumar Das A. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Oct 2021:102321. Link 1 | Request Full-text
  50. 289. COVID-19 associated mucormycosis: A Descriptive Multisite Study from India. Gupta R, Kesavadev J, Krishnan G, Agarwal S, Saboo B, Shah M, Mittal A, Durani S, Luthra A, Singhal A, Rasheed M. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Oct 2021:102322. Link 1 | Link 2
  51. 288. A new interventional home care model for COVID management: Virtual Covid IP. Kesavadev J, Basanth A, Krishnan G, Vitale R, Parameswaran H, Shijin S, Sreelakshmi R, Raj S, Ashik A, Shankar A, Badarudeen S. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021 Jul 23:102228. Read More | Request Full-text
  52. 287. Management Strategies for Dealing With Surges of the COVID-19 Pandemic. Raveendran A, Kesavadev J, Hari P, Krishnan G. Cureus 13(6). June 2021. Read More
  53. 286. Steroid use during COVID-19 infection and hyperglycemia–What a physician should know. Sosale A, Sosale B, Kesavadev J, Chawla M, Reddy S, Saboo B, Misra A. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Jun 2021. Read More | Request Full-text
  54. 285. Impact of Webinars and Telemedicine during COVID-19 Lockdown in Transforming Outcomes in 848 T2D Patients in India. Kesavadev J, Shankar A, Krishnan G, Basanth A, Jothydev K, Chandran B, S. S, Jothydev S. ADA, 81ST Scientific Sessions, Virtual, June 25-29, 2021. 468-P
  55. 284. Comparing Telemedicine with Conventional Diabetes Care in Assessing Long-Term Outcomes in 451 Patients over 15 Years. Kesavadev J, Shankar A, Krishnan G, Ajith J, Basanth A, Jothydev K, Chandran B, S. S, Jothydev S. ADA, 81ST Scientific Sessions, Virtual, June 25-29, 2021. 853-P
  56. 283. Virtual Covid IP Care In Diabetes: Concept to Reality. Kesavadev. J, Shankar. A, Unes. Y, Shijin. S, Manoj. A, Rajalakshmi S, Jose. R, Krishnan G, Jothydev. S. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Oral Presentation Read More
  57. 282. Rediscovering The Power Of Telemedicine (DTMS®) In The Covid Era. Kesavadev J, Saboo B, Shankar A, Krishnan G, Ashok A, Ajith J, Manoj A, S. S, Basanth A, Jyogesh S, Jothydev S. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Read More
  58. 281. Can An Advanced Lancing Device Alleviate Pain And Improve HbA1c? Kesavadev J, Shankar. A, Krishnan G, Chandran B, Basanth A, Sanal G, Krishna V, Jothydev S. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Read More
  59. 280. Using Telemedicine and remote monitoring for diabetes during COVID-19: The Indian experience. Advanced Technologies & Treatments for Diabetes, 14th International Conference, Virtual, June 2021. Invited Lecture- Dr.Jothydev Kesavadev. Read More
  60. 279. Reply to the letter of Draves et al. In response to the article: "Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization" (Kesavadev et al.)". Kesavadev J, Misra A, Saboo B, Aravind SR, Hussain A, Czupryniak L, Raz I. Diabetes Metab Syndr. 2021 Jan-Feb;15(1):466. doi: 10.1016/j.dsx.2021.02.006. Epub 2021 Feb 7. PMID: 33589363. Read More | Request Full-text
  61. 278. DIY artificial pancreas: A narrative of the first patient and the physicians’ experiences from India. Kesavadev J, Saboo B, Kar P, Sethi J. Diabetes & Metabolic Syndrome: Clinical Research & Reviews.March- April 2021;15(2): 615-620; doi.org/10.1016/j.dsx.2021.02.033
    Read More | Request Full-text
  62. 277. Recent Trends in Diabetes Technologies. Dr.Jothydev Kesavadev. Current Trends in Diabetes, Focus on South Asians. Edition 2; Chapter 27. 2021. Read More
  63. 276. Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization. Kesavadev J, Misra A, Saboo B, Aravind SR, Hussain A, Czupryniak L, Raz I. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. January–February 2021: 221-227. Link 1 | Request Full-text
  64. 275. Time-in-range as a target in type 2 diabetes: An urgent need. Saboo B, Kesavadev J, Shankar. A, Krishna M.B, Sheth S, Patel V, Krishnan G. Heliyon. Vol 7(3). Jan 2021: e05967. Read More
  65. 274. Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market. Murthy S, Aneja P, Asirvatham A.J, Husemoen L.L, Rhee N.A, Kesavadev J. Pharmaco Economics-Open, Jan 2021:1-3. Read More
  66. 273. The SAGE Study: Global Observational Analysis Of Glycaemic Control, Hypoglycaemia And Diabetes Management In T1DM. Renard E, Ikegami H, Daher Vianna AG, Pozzilli P, Brette S, Bosnyak Z, Lauand F, Peters A, Pilorget V, Juriši?-Eržen D, Kesavadev J, Seufert J, Wilmot EG. Diabetes/Metabolism Research and Reviews. 2020 Dec 28. Read More | Request Full-text
  67. 272. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel. Chawla M, Jain SM, Kesavadev J, Makkar BM, Viswanathan V, Tiwaskar M, Sosale AR, Negalur V, Modi KD, Gupta M, Kumar S, Ramakrishnan S, Deka N, Roy N. Diabetes Ther. 2020 Dec 12:1–10. doi: 10.1007/s13300-020-00979-8. Read More
  68. 271. Management of children and adolescents having type 1 diabetes during COVID-19 pandemic in India: challenges and solutions. Jethwani P, Saboo B, Jethwani L, Kesavadev J, Kalra S, Sahay R, Agarwal S, Hasnani D. International Journal of Diabetes in Developing Countries. 2020 Sep;40(3):335-9. Read More
  69. 270. Association of nutritional status with dietary and behavioural patterns among adolescents. Elizabeth KE, Ashok AD, Kesavadev J. Int J Contemp Pediatr. 2020 Sep;7(9):1918-1922. Read More
  70. 269. A 2020 Update On Diabetes Technologies With Emphasis On Telemedicine During COVID-19. Kesavadev J. Kerala Medical Journal. Vol 12: issue 3;Jul- Sept 2020: 112-115. | Request Full-text
  71. 268. Tumor Markers in Type 2 Diabetes: Alarming Findings. Kesavadev J, Shankar A, Krishnan G, Jothydev S. RSSDI Annual Case Book-2020, Challenging cases practical solutions. 2020. Chapter 12; 58-64. Read More
  72. 267. Newer insulins on the horizon. Kesavadev J, Ramachandran L. RSSDI’s INSULIN Monograph (A Complete Guide to Insulin Therapy). Jaypee Brothers Medical Publishers (P) Ltd. 2020. 138-143. Read More
  73. 266. Is Time-in-Range Independent of A1C? A Study in Asian Indian Population. Kesavadev J, Shankar A, Krishnan G, Saboo B. D, Sanal G, Krishna M, Sanal T. S, Jothydev S. Diabetes 2020 Jun, 69 (Supplement 1) 880-P; DOI: 10.2337/db20-880-P Read More
  74. 265. Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas. Kesavadev J, Saboo B, Krishna M.B, Krishnan G. Diabetes Ther. Jun 2020;10.1007/s13300-020-00831-z. Read More
  75. 264. Diabetes and coronavirus disease-2019 (COVID-19). Unnikrishnan R, Saboo B, Kesavadev J, Deshpande N, Ramachandra Aravind S. R, Joshi S, Anjana R. M, Hussain A, Mohan V. J Diabetol. Jun 2020;11:52-6. Read More
  76. 263. Time in Range: The new metric in diabetes. Kesavadev J. M3 India Originals. May 13 2020. Read More
  77. 262. Harnessing the Possibilities of Telemedicine for Consultations in COVID Crisis.Kesavadev J. Int J Diab May 2020;1-6. | Request Full-text
  78. 261. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review. Kesavadev J, Srinivasan S, Saboo B, Krishna M. B, Krishnan G. Diabetes Ther. Apr 2020. | Read More
  79. 260. Real-world Data Reveal Unmet Clinical Needs in Insulin Treatment in Asian People With Type 2 Diabetes: The Joint Asia Diabetes Evaluation (JADE) Register. Kong A. P. S, Lew T, Lau E. S. H, Lim L. L, Kesavadev J, Jia W, Sheu W H-H, Sobrepena L, Tan A. T. B, Nguyen T. K, Yoon K. H, Wang K, Kodiappan K, Treuer T, Chan J. C. N, JADE Collaborative Study Group. Diabetes Obes Metab.Apr 2020;22(4):669-679. Link 1 | Link 2 | Request Full-text
  80. 259. AGP in Clinical Practice and 'Time in Range - A new dimension in T2DM monitoring. Invited Lecture- Dr. Jothydev Kesavadev. 10TH World Congress of DiabetesIndia, , Bengaluru, India. February 2020
  81. 258. Utility of a Glucose meter with Bluetooth and Web Connectivity in Aiding Physicians and Patients Achieve Better Glycemic Levels. Kesavadev J, Krishnan G, Shankar A, Ashok A, Shamsudeen J, Thampiraj K, Manu A, Jothydev S. Diabetes Technol Ther. 2020 Feb.22(S1). A109. Link 1 | Link 2
  82. 257. Outlining the Relationship Between Time In Target (TIT) and HbA1c in Asian Indians with Diabetes. Kesavadev J, Shankar A, Warrier R, Krishnan G, Shamsudeen J, Jothydev S. Diabetes Technol Ther. 2020 Feb. 22(S1). A131. Link 1 | Link 2
  83. 256. CGM for diabetes management. Kesavadev J. M3 India Originals. Feb 10 2020. Read More
  84. 255. Real - world evidence of improved glycemic control among older adults with T2DM undergoing integrated care for 10 years. Kesavadev J, Shankar A, Chandrika B. B, Sanal G, Krishnan G, Jothydev S. OP-0197. Read More
  85. 254. Real - world assessment of glycemic control among female diabetes subjects: an observational cohort study. Kesavadev J, Chandrika B. B, Ramachandran L, Ajai A, Krishnan G, Jothydev S. Dec 2019, P-0759. Read More
  86. 253. The impact of unproven therapies in diabetes and the role of education. Kesavadev J, Sadikot S, Saboo B, Joshi S, Chandrika B. B, Jothydev S. OP-0188. Read More
  87. 252. An evaluation of the prescription pattern of IDegAsp and its clinical outcomes in Indian clinical practice. Kesavadev J, Saboo B, Joshi S, Shankar A, Ashok A. D, Ramachandran L, Jothydev S. Dec 2019, OP-0543. Read More
  88. 251. One year JADE-assisted integrated diabetes care improves cardiometabolic control in 4 low - and middle-income countries. Lim L, Lau E. S, Chia Y. C, Ray S, Krishna S.A, Cruz M. C. A, Soegonda S, Kesavadev J, Aravind S. R, Fu A. W, Luk A. O, Chan J. C. Dec 2019
  89. 250. Initial pump setting, further adjustment and fine tuning. Invited lecture - Dr.Jothydev Kesavadev. Annual Meeting of Research Society for the study of Diabetes in India, Jaipur. Nov 2019.
  90. 249. Changing Diabetes Care: from Glycemia to CVD. Invited lecture - Dr.Jothydev Kesavadev. Annual Meeting of Research Society for the study of Diabetes in India, Jaipur. Nov 2019.
  91. 248. Utility of the First Generation Artificial Pancreas & The Factors Influencing the Frequency of Sensor Use: Indian Real-World Data. Invited lecture - Dr.Ashwin David. Annual Meeting of Research Society for the study of Diabetes in India, Jaipur. Nov 2019.
  92. 247. Role of risk scores to identify high risk population: global and Indian. Invited lecture - Dr. Arun Shankar. Annual Meeting of Research Society for the study of Diabetes in India, Jaipur. Nov 2019.
  93. 246. Consensus and recommendations on continuous glucose monitoring. Chawla M, Saboo B, Jha S, Bhandari S, Kumar P, Kesavadev J, Munjal YP, Mohan V, Unnikrishnan R, Katswar V, Arun N, Sosale B, Anjana RM, Hasnani D. J Diabetol. Nov 2019. 10. 4-14. Read More
  94. 245. Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic Drugs. Unnikrishnan AG, Saboo B, Joshi S, Kesavadev J, Makkar BM, Agarwal S, Aravind SR, Seshadri K, Chawla M, Deshpande N, Chawla R, Tiwaskar M. J Assoc Physicians India.Nov 2019. 67(11). 76-83. Read More
  95. 244. Unproven Therapies for Diabetes. Kesavadev J, Ramachandran L, Kalra, S. The Diabetes Textbook. Springer. 2019. 999-1013. Read More
  96. 243. Inertia for the Use of Technological Advances for Effective Diabetes Management. Kesavadev J. Int J Diab Sep 2019.1-2. Editorial. | Request Full-text
  97. 242. Pathophysiology of Type 2 Diabetes. Kesavadev J, Jawad F, Deeb A, Coetzee A, Jalil Ansari M. A, Shrestha D, Somasundaram N, Kalra S. The Diabetes Textbook. Springer. Jun 2019. 101-116. Read More
  98. 241. Early insulin initiation in T2DM is associated with prevention of eGFR decline and lower insulin dose requirements. Kesavadev J, Warrier R, Shankar A, David A, Ajai N. A, Sanal G, Thampiraj K, Ramachandran L, Krishnan G, Jothydev S. Diabetes 2019 Jun, 68 (Supplement 1) 530-P; DOI: 10.2337/db19-530-P. Link 1 | Link 2
  99. 240. Improving the Quality of Life of T1DM Patients in a Community: A KT1DP Initiative. Kesavadev J, Saboo B. D, Shankar A, David A, Warrier R, Ajai N. A, Sanal G, Thampiraj K, Ramachandran L, Krishnan G, Jothydev S. Diabetes Jun 2019, 68 (Supplement 1) 2259-PUB; DOI: 10.2337/db19-2259-PUB. Read More
  100. 239. Consistency and Predictability of Control of Glycemic Variability with U200 (Concentrated r-DNA Human Insulin Premix 30/70-200 IU/mL) in Type 2 Diabetes Mellitus Patients. Thacker H, Kesavadev J, Ingole S. A, Shah A, Jain R. Diabetes Jun 2019, 68 (Supplement 1) 2322-PUB; DOI: 10.2337/db19-2322-PUB. Read More
  101. 238. Clinical Decision Support System for Healthcare Professionals. Invited lecture - Dr.Jothydev Kesavadev. World Congress in Diabetes, Jaipur, India. Mar 2019.
  102. 237. Practice Changing User Friendly Diabetes Technologies - New for 2019 and beyond. Invited lecture - Dr.Jothydev Kesavadev. World Congress in Diabetes, Jaipur, India. Mar 2019.
  103. 236. Insulin pump vs multiple daily Injections: Evidence on Merits and Demerits in Type 1 and Type 2 Diabetes. Invited lecture - Dr.Jothydev Kesavadev. World Congress in Diabetes, Jaipur, India. Mar 2019.
  104. 235. An Ideal Basal insulin to beat macro-clock hypothesis from Indian Perspective. Invited lecture - Dr.JothydevKesavadev. World Congress in Diabetes, Jaipur, India. Mar 2019.
  105. 234. Harnessing the Power of Social Media for a Structured and Instant Intervention, Education and Counselling in Type 1 Diabetes. Kesavadev J, Shankar A, David A, Sanal G, Ajith J, Krishnan G, Ramachandran L, Jothydev S. Diabetes Technol Ther. 2019 Feb. 21. A116. Link 1 | Link 2 | Link 3
  106. 233. Assessing the Benefits of a Painless Lancing Device in a Subset of Patients Fearful of Finger Pricking. Warrier R, Badarudeen S, Shankar A, Krishnan G, Ramachandran L, Thampiraj K, Jothydev S, Kesavadev J. Diabetes Technol Ther. 2019 Feb. 21. A60-A61. Link 1 | Link 2 | Link 3
  107. 232. Recommendations for in-clinic PoCT for diabetes management in India. Saboo B, Sadikot S, Prasanna Kumar KM, Joshi S, Aravind SR, Makkar BM, Chawla R, Kesavadev J, Chawla M, Kovil R, Shah T, Mohit M, Vyas C, Dhandhania VK. Diabetes Metab Syndr. Jan-Feb 2019. 13(1). 5-7. Read More
  108. 231. Indications For iDegLira In Indian Clinical Practice- Insights Gained From Our Experience and Utility Of The First Generation Artificial Pancreas. Kesavadev J, Shankar A, David A, Krishnan G, Jayanthi S, Ramachandran L, Jothydev S. Nov 2018. Read More
  109. 230. Utility Of The First Generation Artificial Pancreas And The Factors Influencing The Frequency Of Sensor Use: An Indian Real-World Data. Shankar A, David A, Krishnan G, Anilkumar A, Ramachandran L, Jothydev S, Kesavadev J. Nov 2018. Read More
  110. 229. Current Technologies in Diabetes Management. Invited Lecture: Dr. Jothydev Kesavadev. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  111. 228. AGP - A Novel Tool to Personalize Diabetes Management for each Patient. Invited Lecture: Dr. Jothydev Kesavadev. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  112. 227. Dexcom - Real Time CGM (in Product Theatre). Invited Lecture: Dr. Jothydev Kesavadev. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  113. 226. Funding Opportunities for Research projects. Invited Lecture: Ms. Gopika Krishnan. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  114. 225. Insulin Pump Workshop: Basic Information on Pump & Indication. Invited Lecture: Dr. Arun Shankar. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  115. 224. Insulin Pump Workshop: Closed Loop Pump System - Future Treatment for Diabetes. Invited Lecture: Dr. Rohit Warrier. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  116. 223. Impact of a Comprehensive Disease Management Model vs Conventional Care in Long Standing Diabetes. Invited Lecture: Ms. Geethu Sanal. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  117. 222. Dietary Carbohydrate Consumption in Diabetes Patients and Normal Individuals" - Data from South India. Invited speaker - Ms. Geethu Sanal. Annual Meeting of Research Society for the Study of Diabetes in India, Ahmedabad, Nov 2018.
  118. 221. Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus. Kalra S, Kesavadev J,Chadha M, Kumar G. V. Indian J Endocrinol Metab. Nov 2018. 22(6). 827–836. Read More
  119. 220. JADE Collaborative Study Group. Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation Program. Gani L, Lau E, Luk A, Sobrepena L, Tran Q.K, Kesavadev J, Jia W, Yu W, Tsang C.C, Mukhopadhyay M, Jha S, Sheu W, Ho Y.K, Nguyen T.K, Ozaki R, So W.Y, Kwan C, Fu A.W.C, Mirasol R, Phatak S.R, Kumar K.M.P, Aravind S, Janakiraman H, Chan J.C.N. J Diabetes Investig. 2018 Nov;9(6):1312-1322. PMID: 29575724; PMCID: PMC6215931. | Request Full-text
  120. 219. Islet transplants: Now and later importance of social media and communications in education and prevention of diabetic complications. IDF Diabetes Complications Congress, Hyderabad, India, 25-27 Oct, 2018. Read More
  121. 218. Providing free insulin pumps to T1D children: challenges and opportunities- insights from our KT1DP initiative (Session: DM in Developing Countries & Nutrition). Invited Speaker: Dr.Jothydev Kesavadev. ISPAD 44th Annual Conference, Hyderabad, 11-14 October 2018. Read More
  122. 217. Insulin pumps vs. MDI-what is the current position in Type 1 diabetes. Invited Speaker: Dr.Jothydev Kesavadev. ISPAD 44th Annual Conference, Hyderabad, 11-14 October 2018.
  123. 216. Insulins and other injectables in managing diabetes and its complications. Dr. Jothydev Kesavadev. Oct 2018. Read More
  124. 215. Preventing diabetes complications with telemedicine - Insights gained from a real-world 20 year follow-up data Oral presentation-.Kesavadev J, Shankar A, Ashok A. D, Krishnan G, Ajai N. A, Sanal G, Ajith J, Jayanthi S, Ramachandran L, Jothydev S.: Presenter: Ms.Gopika Krishnan. Oct 2018. Read More
  125. 214. Practice Changing User Friendly Diabetes Technologies - New for 2018 and beyond. Invited Speaker: Dr.Jothydev Kesavadev. Diacon 2018 Gold Medal Oration, Ahmedabad. Sep, 2018
  126. 213. Closed Loop Pump System - Future Treatment for Diabetes. Invited Speaker: Dr.Jothydev Kesavadev. September 21 to 23, 2018: Diacon 2018 Gold Medal Oration, Ahmedabad.
  127. 212. Insulin Pump Workshop. Invited Speaker: Dr.Jothydev Kesavadev. September 21 to 23, 2018: Diacon 2018 Gold Medal Oration, Ahmedabad. Read More
  128. 211. Exploratory CSII Randomized Controlled Trial on Erectile Dysfunction in T2DM Patients (ECSIITED). Kesavadev J, Pillai P. B. S, Shankar A, Warrier R. S, Ramachandran L, Jothydev S, Krishnan G. J Diabetes Sci Technol. Aug 2018. 12(6). 1252–1253. Read More
  129. 210. Are Complications Preventable with Periodic Education via Telemedicine? A Study of 414 Compliant T2D Patients Followed Up for 19 Years. Kesavadev J, Shankar A, David A, Krishnan G, Ajai N. A, Sanal G,Ajith J, Jayanthi S, Ramachandran L, Jothydev S.Diabetes Jul 2018, 67 (Supplement 1) 685-P; DOI: 10.2337/db18-685-P. Link 1 | Link 2 | Link 3
  130. 209. Enabling Data-Driven Decision Making for Personalized Care in Type 2 Diabetes with Clinical and Lifestyle Journey Data Using a Digital Therapeutic. Chawla R, Shaikh M, Shah A, Saboo B. D, Makkar B. M, Kesavadev J, Joshi S, Deshpande N, Agarwal S, Maheshwari A, Sosale A. Madhu S. V. Diabetes Jul 2018, 67 (Supplement 1) 248-OR; DOI: 10.2337/db18-248-OR. Link 1 | Link 2
  131. 208. Efficacy of a Basal-Plus Regimen. Saboo B. D. J, Hasnani D, Chandarana H, Bhandari S, Joshi S, Kesavadev J, Maheshwari A, Thacker H.Diabetes Jul 2018, 67 (Supplement 1) 2292-PUB; DOI: 10.2337/db18-2292-PUB. Link 1 | Link 2
  132. 207. Conversational Artificial Intelligence for Achieving Activity Targets through Routine Physical Activity-Longitudinal Observational Study among People with Type 2 Diabetes. Makkar B. M, Shaikh M, Shah A, Joshi S, Saboo B. D, Sosale A. R, Madhu S. V, Kovil R, Shah T, Chawla M. S, Chawla R, Kesavadev J.Diabetes Jul 2018, 67 (Supplement 1) 750-P; DOI: 10.2337/db18-750-P. Link 1 | Link 2 | Link 3
  133. 206. One-Year Safety and Effectiveness of Insulin Degludec in Patients with Diabetes Mellitus in Routine Clinical Practice in India-TRUST (Tresiba Real-World Use Study). Kesavadev J, Murthy L. S, Saboo B. D, Yalamanchi S. R, Ramanathan B, Gupta S, Chatterjee S, Revanna M, Kasetty H. Diabetes Jul 2018, 67 (Supplement 1) 1019-P; DOI: 10.2337/db18-1019-P. Link 1 | Link 2
  134. 205. Continuous Glucose Monitoring Guided Assessment of Concentrated U200 r-DNA Human Premix 30/70 Insulin. Thacker H, Kesavadev J, Singh G, Shukla K, Puppalwar G, Shrimanker R. Diabetes Jul 2018, 67 (Supplement 1) 1013-P; DOI: 10.2337/db18-1013-P. Link 1 | Link 2 | Link 3
  135. 204. Real-World Effectiveness of a Digital Therapeutic in Improving Glycaemic Control in South Asians Living with Type 2 Diabetes. Sosale A. R, Sr., Shaikh M, Shah A, Chawla R, Makkar B. M, Kesavadev J, Joshi S, Deshpande N, Agarwal S, Maheshwari A, Madhu S, Saboo B. D. Read More
  136. 203. Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DM. Saboo B, Sheth SV, Joshi S, Bhandari S, Kesavadev J, Maheshwari A, Agrawal M, Hasnani D, Patel F, Panchal D, Goklani R. J Assoc Physicians India. Jul 2018. 66(7).69-71. Read More
  137. 202. IDegAsp Improves Glycemic Control with Minimal Hypoglycemia-An Indian Real-World Study in T2D Subjects. Kesavadev J, Saboo B. D, Shankar A, David A, Warrier R, Krishnan NG, Ramachandran L, Jothydev SDiabetes. 2018 Jun;67(Supplement 1). 389-P; DOI: 10.2337/db18-389-P. Link 1 | Link 2 | Link 3 | Link 4
  138. 201. Insulin delivery methods: past present future. Invited Lecture: Dr.Jothydev Kesavadev. 10th International Conference on Advances in Diabetes and Insulin Therapy (ADIT), Dubrovnik, Croatia, 15 - 17 April, 2018.
  139. 200. Emerging Diabetes Technologies Diabetes in the Elderly - How do they differ? Invited Speaker: Dr.Jothydev Kesavadev. Emirates Diabetes and Endocrine Congress (EDEC 2018), Dubai, 01 - 03 March, 2018.
  140. 199. Insulin Pump Therapy vs MDI - What is the Current Position in Type 1 Diabetes Mellitus? Invited Speaker: Dr.Jothydev Kesavadev. Emirates Diabetes and Endocrine Congress (EDEC 2018), Dubai, 01 - 03 March, 2018. Read More
  141. 198. Insulin pumps vs. MDI - what is the current position in Type 1 diabetes. Invited lecture - Dr.Jothydev Kesavadev. World Congress of DiabetesIndia, Kolkata, India. Feb 2018.
  142. 197. Insulin treatment in Elderly. Invited lecture - Dr.Jothydev Kesavadev. World Congress of DiabetesIndia, Kolkata, India. Feb 2018. World Congress of DiabetesIndia, Kolkata, India. Feb 2018.
  143. 196. 'Insulin pump'- Devices in Diabetes - Everything that a Physicians needs to Know'. Invited lecture - Dr.Jothydev Kesavadev. World Congress of DiabetesIndia, Kolkata, India. Feb 2018.
  144. 195. SMBG and virtual consultation via DTMS®: 20 years' experience. Invited Lecture: Dr. Jothydev Kesavadev. Diabetes Technol Ther. 2018 Feb. 20(S1). A5-A6. Link 1 | Link 2
  145. 194. Use of Insulin Pumps in T2DM in India: Merits and Demerits learnt over a decade. Invited lecture-Dr.Jothydev Kesavadev. Advanced Technologies & Treatments for Diabetes, 11th International Conference, Austria, Feb 14-17, 2018. Read More
  146. 193. Patient and caregiver feedback on the first generation Artificial Pancreas in India. Kesavadev J, Ramachandran L, Shankar A, David A, Jose R, Anilkumar A L, Krishnan G, Jothydev S. Diabetes Technol Ther.2018 Feb. 20(S1). A55-A56. Link 1 | Link 2
  147. 192. Utility of a multi-model bot enabled, and doctor led intervention for diabetes management- clinician and patient perspectives. Kesavadev J, Saboo B, Ramachandran L, Shankar A, David A, Krishnan G, Jothydev S. Diabetes Technol Ther.2018 Feb. 20(S1).A39- A40. Link 1 | Link 2
  148. 191. Diabetes duration-based initiation of insulin: impact on clinical outcomes, insulin dosage and quality of life. Kesavadev J, Saboo B, Shankar A, David A, Jothydev K, Ramachandran L, Krishnan G, Jothydev S. Diabetes Technol Ther. 2018 Feb. 20(S1). A149-A150. Link 1 | Link 2
  149. 190. Effectiveness of a digital therapeutic for improving outcomes in South Asians living with type-2 diabetes - results from an ongoing real-world pilot trial. Saboo B, Shaikh M, Shah A, Sosale A, Kesavadev J, Chawla M, Makkar B M, Kovil R, Chawla R, Bajaj S. Diabetes Technol Ther. 2018 Feb. 20(S1). A79-A80. Link 1 | Link 2
  150. 189. Our First 825 T2DM Patients on 14-Day Factory-Calibrated Glucose Monitoring System: Clinical Utility and Challenges. Kesavadev J, Shankar A, Ashok A.D, Srinivas S, Ajai N. A, Sanal G, Krishnan G, Ramachandran L, Jothydev S. J Diabetes Sci Technol. Jan 2018. 12(1). 230–231. Read More
  151. 188. Insulin delivery methods - Past, present and future. Invited Lecture: Dr. Jothydev Kesavadev. IDF Congress, Abu Dhabi, UAE, Dec 2017.
  152. 187. Living with diabetes - Diabetes Education. Invited Lecture: Ms. Gopika Krishnan. IDF Congress, Abu Dhabi, UAE, Dec 2017.
  153. 186. Living with diabetes - Diabetes Education. Invited Lecture: Ms. Gopika Krishnan. The impact of un-proven complementary and alternative medicine practices in diabetes management - an Indian scenario. P-1198.Kesavadev J, Shankar A, Ashok A. D, Ramachandran L, Krishnan G, Jothydev S. IDF. Dec 2017. Read More
  154. 185. Free insulin pumps to type 1 diabetes children - KT1DP initiative. P- 1225. Kesavadev J, Shankar A, Ashok A. D, Skaria L, Manu A, Sanal G, Krishnan G, Ramachandran L, Jothydev S. IDF. Dec 2017. Read More
  155. 184. Elderly living alone with diabetes - an emerging major social issue? P 1211.Kesavadev J, Shankar A, Ashok A. D, Ramachandran L, Krishnan G, Jothydev S. IDF. Dec 2017. Read More
  156. 183. Evaluation of 24 hour glycemic control in T2DM patients receiving the novel formulation of U-200 human pre-mix insulin. P-0340. Kesavadev J, Shankar A, Krishnan G, Vinod K, Mane K, Katare S, Rao S, Barkate H. IDF. Dec 2017. Read More
  157. 182. Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes. Ghosh S, Unnikrishnan A. G, Saboo B, Kesavadev J, Aravind S. R, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar B. M, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar T. K. M, Maheshwari A, Pendsey S, Phatak S. R, Sharma S. K, Singh S. K, Ramachandran A, Zargar A. H, Joshi S. R, Sadikot S. M. Diabetes Metab Syndr. Nov 2017. 11(S1). S507-S521. Read More
  158. 181. Sitagliptin 100mg vs glimepiride 1–3mg as an add-on to insulin and metformin in type 2 diabetes (SWIM). Kesavadev J, Pillai P. B. S, Shankar A, Krishnan G, Jothydev S. Endocr Connect. Nov 2017. 6(8). 748–757. Read More
  159. 180. In Hospital Management of Diabetes mellitus. Kesavadev J. API Progress in Medicine 2017.
  160. 179. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes. Anjana R. M, Kesavadev J, Neeta D, Tiwaskar M, Pradeepa R, Jebarani S, Thangamani S, Sastry N. G, Kumar B. S, Ramu M, Gupta P. P. K, Vignesh J, Chandru S, Kayalvizhi S, Jagdish P. S, Uthra S. C. B, Lovelena M, Jyoti S, Priya S. S, Kannan A, Mohan V, Unnikrishnan R. Diabetes Technol Ther. Sep 2017. 19(9). 533-540. Read More
  161. 178. Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation. Kesavadev J, Vigersky R, Shin J, Pillai P. B. S, Shankar A, Sanal G, Krishnan G, Jothydev S. Adv Ther. Aug 2017. 34(8). 1918-1927. Read More | Request Full-text
  162. 177. Liraglutide and Renal Outcomes in Type 2 Diabetes. Mann J. F. E , Ørsted D. D , Frandsen K. B, Marso S. P, Poulter N.R, Rasmussen S , Tornøe K, Zinman B , Buse J. B , LEADER Steering Committee and Investigators. N Engl J Med. Aug 2017 31;377 (9):839-848. Link 1 | Link 2
  163. 176. Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017. Tandon N, Kalra S, Balhara Y. P. S, Baruah M. P, Chadha M, Chandalia H. M, Kumar K. M. P, Madhu S. V, Mithal A, Sahay R, Shukla R, Sundaram A, Unnikrishnan A. G, Saboo B, Gupta V, Chowdhury S, Kesavadev J, Wangnoo S. K. Indian J Endocrinol Metab. Jul-Aug 2017. 21(4). 600–617. Read More
  164. 175. Clinical practice points for diabetes management during RAMADAN fast. Sadikot S. M, Jothydev K, Zargar A. H, Ahmad J, Arvind S. R, Saboo B. Diabetes Metab Syndr. Jun 2017. 11(S2). S811-S819. Read More
  165. 174. Halting CKD Progression in Diabetes with Virtual Interactions- a 5 year Retrospective Analysis. Kesavadev J, Shankar A, Sanal G, Ramachandran L, Krishnan G, Jothydev S. Diabetes 2017 Jun, 66 (Supplement 1) 2282- PUB; DOI: 10.2337/db17-2282- PUB. Read More
  166. 173. Use of Flash Glucose Monitor to Optimize the Dose of Basal Insulin Glargine-Real-World Clinical Data. Patel F, Goklani R, Saboo B, Hasnani D, Maheshwari A, Kesavadev J, Joshi S. R. Diabetes 2017 Jun, 66 (Supplement 1) 939 P; DOI: 10.2337/db17- 939 P. Link 1 | Link 2
  167. 172. Sharing the Outcomes and User Experience from India in The First 750 Type 2 Diabetes Patients with the New Libre Pro 14-Day Glucose Sensor. Kesavadev J, Ramachandran L, Shankar A, David A, Krishnan G, Srinivas S, Ajai A, Sanal G, Jothydev S. Diabetes 2017 Jun, 66 (Supplement 1) LB27-LB28; DOI: 10.2337/db17- LB27-LB28. Link 1 | Link 2 | Link 3
  168. 171. The significance of repeated education in correcting insulin injection techniques and improving glycemic control. Kesavadev J, David A, Shankar A, Sowmya J, Ramachandran L, Krishnan G ,Jothydev S. Diabetes 2017 Jun, 66 (Supplement 1) 716-P; DOI: 10.2337/db17- 716-P. Link 1 | Link 2 | Link 3
  169. 170. Validation for Artificial Intelligence Leveraging Patient-Centric User Experience for Behavior Change in Subjects with Type 2 Diabetes. Aravind S. R, Saboo B. D, Shah T, Joshi S. S, Shaikh M, Subnis U, Shah A, Kesavadev J. Diabetes 2017 Jun, 66 (Supplement 1) 367 OR; DOI: 10.2337/db17- 367 OR. Link 1 | Link 2 | Link 3
  170. 169. Treatment Outcomes with Liraglutide in New Onset Type 2 Diabetes - A Retrospective Analysis. Kesavadev J, Shankar A, Thacker H, Ramachandran L, Jose R, Krishnan G, Jothydev S. A239. 52. Link 1 | Link 2
  171. 168. Improved Short Term and Long Term Outcomes of Early Insulin Initiation in Type 2 Diabetes over 10 Years. Kesavadev J, Joshi S, Saboo B, Thacker H, Shankar A, David A, Sanal G, Ramachandran L, Krishnan G, Jothydev S. A238. 51. Link 1 | Link 2
  172. 167. Efficacy of Teneliglitpin as Monitored with Continuous Glucose Monitoring System (CGMS) in Comparison with Standard of Care in Indian Setting. Thacker H, Kesavadev J, Shrimanker R. A257. 61. Link 1 | Link 2
  173. 166. Consensus on Initiation and Intensification of Premix Insulin in Type 2 Diabetes Management. Mohan V, Kalra S, Kesavadev J, Singh A. K, Kumar A, Unnikrishnan A. G, Chawla R, Mukherjee J.J, Sahay R. K, Kumar J. S, Bhoraskar A, Asirvatham A. J, Panda J. K, Zargar A. H, Das A. K. J Assoc Physicians India. Apr 2017. 65(4). 59-73. Read More
  174. 165. Consensus recommendations on exploring effective solutions for the rising cost of diabetes. Sadikot S. M, Das A. K, Wilding J, Siyan A, Zargar A. H, Saboo B, Aravind S. R, Sosale B, Kalra S, Vijayakumar G, Manojan K. K, Maheshwari A, Panda J. K, Banerjee S, Chawla R, Vasudevan S. P, Sundar O. S. S, Kesavadev J. Diabetes Metab Syndr. Mar 2017. 11(2). 141-147. Link 1 | Request Full-text
  175. 164. Efficacy and safety concerns regarding Complementary and Alternative Medicine use among diabetes patients. Kesavadev J. J Pak Med Assoc. 2017. 67(2). 316-319. Read More
  176. 163. Better outcomes in type 2 diabetes management with a user friendly flash glucose monitoring system- Freestyle Librepro. Oral Presentation: Dr.Jothydev Kesavadev. Advanced Technologies & Treatments for Diabetes, 10th International Conference, Paris, France, Feb 15-18, 2017. Read More
  177. 162. Twice Daily IDegAsp Compared To BIAsp Further Reduces HbA1c with Negligible Hypoglycemia. Shankar A, Kesavadev J, David A, Ramachandran L, Krishnan G, Jothydev S.Feb 2017. Read More
  178. 161. Exploring Reasons for Insulin Pump Failure and Suggested Solutions. Kesavadev J, Saboo B, Shankar A, Srinivas S, Ajai A, Sanal G, Ramachandran L, Krishnan G, Jothydev S. Feb 2017. Read More
  179. 160. Consensus on Insulin Dose and Titration Algorithms in Ambulatory Care of Type 2 Diabetes in India. Kovil R, Chawla M, Rajput R, Singh A. K, Sinha B, Ghosal S, Ballani P, Gupta S, Tanna S, Bandukwala S. M, Shah T, Negalur V, Bhoraskar A, Aravind S. R, Zargar A. H, Kesavadev J, Das A. K. J Assoc Physicians India. Feb 2017. 65(2). 17-30. Read More
  180. 159. Is Cancer Screening in Diabetes Justified? Insights from Electronic Medical Records. Kesavadev J, Shankar A, Ramachandran L, Krishnan G, Jothydev S. Diabetes Technol Ther.2017 Feb. 19(S1). A1-A133. Read More
  181. 158. Better Outcomes in Type 2 Diabetes Management with a User Friendly Flash Glucose Monitoring System: Freestyle Libre Pro. Kesavadev J, Krishnan G, Saboo B, Shankar A, Ashok AD, Sanal G, Ramachandran L, Jothydev S. Diabetes Technol Ther. 2017 Feb.19(S1).A1-A133. Read More
  182. 157. Bionic Pancreas: The Dream Come True? Invited talk: Dr.Jothydev Kesavadev. World Congress of Diabetes India, New Delhi. Feb 2017.
  183. 156. The limitation of HbA1c - Flash Glucose Monitoring: Clinical Use. Invited talk: Dr.Jothydev Kesavadev. World Congress of Diabetes India, New Delhi. Feb 2017.
  184. 155. Mental Health Issues Before and After Bariatric Surgery. Invited talk: Mrs.Sunitha Jothydev. World Congress of Diabetes India, New Delhi. Feb 2017.
  185. 154. Glucose monitoring technologies - Complementary or competitive? Role of Continuous Glucose Monitoring versus flash glucose monitoring versus self-monitoring of blood glucose. Kesavadev J, Ramachandran L, Krishnan G. J Diabetol. Jan 2017. 8(3). 61-67. Review. Read More
  186. 153. Unproven Therapies for Diabetes and Their Implications. Kesavadev J, Saboo B, Sadikot S, Das A. K, Joshi S, Chawla R, Thacker H, Shankar A, Ramachandran L, Kalra S. Adv Ther. 2017. 34(1). 60-77. Read More
  187. 152. Insulin Pump Therapy : How to choose the right candidate. Invited lecture: Dr.Jothydev Kesavadev. Annual Meeting of Research Society for the Study of Diabetes in India, Hyderabad. Nov 2016.
  188. 151. Cancer In Diabetes : Is It An Evolving Complication Of Poor Glycemic Control? Kesavadev J, Shankar A, Jose R, Ramachandran L, Jothydev S. 44th Annual Meeting of Research Society for the Study of Diabetes in India, Hyderabad, 18-20 Nov, 2016.
  189. 150. Impact of a Comprehensive Disease Management Model vs Conventional Care in Long Standing Diabetes. Kesavadev J, Shankar A, Sanal G, Ramachandran L, Jothydev S. 44th Annual Meeting of Research Society for the Study of Diabetes in India, Hyderabad, 18-20 Nov, 2016.
  190. 149. Platelet Proteins From Diabetic Subjects Cause Phenotypic Changes In Endothelial Cells In-Vitro. Hilary S, Shahna S, Kesavadev J ,Bhatt A. International Journal Of Life Science And Pharma Research. 2016. 7(1). 61-71. Read More
  191. 148. Insulin pump therapy in pregnancy. Kesavadev J. J Pak Med Assoc. Sep 2016. 66(9S1). S39-44.Review. Read More
  192. 147. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. Marso S. P , Daniels G. H , Frandsen K. B , Kristensen P , Mann J. F. E , Nauck M. A , Nissen S. E , Pocock S , Poulter N. R , Ravn L. S , Steinberg W. M , Stockner M , Zinman B, Bergenstal R.M, Buse J. B , LEADER Steering Committee; LEADER Trial Investigators. N Engl J Med. 2016 Jul 28;375(4):311-22. Link 1 | Link 2
  193. 146. Comparison of the New Factory Calibrated Sensor with Existing CGM Sensor. Kesavadev J, Pillai P. B. S, Shankar A, Ashok A.D, Sanal G, Iyer R, Krishnan G, Jothydev S. Diabetes Jun 2016, 65 (Supplement 1) P896; DOI: 10.2337/db16- P896. Link 1 | Link 2 | Link 3
  194. 145. How Successful Is Lifestyle Advice in Preventing the Progression of Prediabetes to Diabetes? Kesavadev J, Shankar A, Pillai P. B. S, Lally J, Krishnan G, Sanal G, Jothydev S.Diabetes Jun 2016, 65 (Supplement 1) 724-P; DOI: 10.2337/db16- 724-P. Link 1 | Link 2 | Link 3
  195. 144. Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India. Mohan V, Jain S, Kesavadev J, Chawla M, Mutha A, Viswanathan V, Saboo B, Kovil R, Mithal A, Punatar D, Shin J. J Assoc Physicians India. Apr 2016. 64(4). 16-21. Read More
  196. 143. CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective. Kesavadev J, Shankar A, Pillai P. B. S, Saboo B, Joshi S, Krishnan G, Jothydev S. Curr Diabetes Rev. 2016. 12(4). 312-314. Read More
  197. 142. Insulin Pump Therapy: How to Choose the Right Candidate. Kesavadev J. Chapter 8. RSSDI Diabetes Update 2016.
  198. 141. Evolution of Path-breaking Technologies in Diabetes. Kesavadev J. Chapter 21. Volume 2. API Progress in Medicine 2016.
  199. 140. Periodic follow up with telemanagement system for 15 years and significant reduction in vascular complications in T2DM. Kesavadev J, Shankar A, Krishnan G, Jothydev S. Diabetes Technol Ther. 2016 Feb. 18(S1). A92-A-93. Link 1 | Link 2 | Link 3
  200. 139. Comparing IPRO with Libre for Sensor Accuracy and User Friendliness. Kesavadev J, Shankar A, Sanal G, Krishnan G, Jothydev S, Pillai P. B. Diabetes Technol Ther. 2016 Feb. 18(S1). A74. Link 1 | Link 2 | Link 3
  201. 138. Extending Metformin Benefits in Patients with Type 2 Diabetes through Pill Technology: A Systematic Review of Nine Pooled Clinical Trials. Kumar S, Gupta S, Kumar A, Tiwaskar M, Sharma S, Kesavadev J, Thacker H, Wadhwa N, editors. Diabetes Technol Ther. 2016 Feb. 18(S1). A130-A131. Link 1 | Link 2
  202. 137. Going beyond HbA1c-Ambulatory glucose profiling. Invited Speaker: Dr.Jothydev Kesavadev. January 28-31, 2016: APICON 2016. Read More
  203. 136. The two levels of care for diabetes in a developing country: Mechanisms for improved intermediate health outcomes. Vitale R. J, Pillai P. B, Krishnan G, Jothydev S, Kesavadev J. Diabetes Metab Syndr. Jan- Mar 2016. 10(1S1).S90-S94. Read More
  204. 135. How significant are wrong injection techniques in a real world diabetes care setting? Kesavadev J, Shankar A, David A, Sanal G, Lally J, Shiju S, Krishnan G, Jothydev S. IDF Congress, Vancouver, British Columbia, Canada, Nov-Dec, 2015. Read More
  205. 134. Cost effective customisation of targets: Outcomes after 12 years of telemedicine in 853 patients with type 2 diabetes. Kesavadev J, Shankar A, David A, Sanal G, Lally J, Krishnan G, Jothydev S. IDF Congress, Vancouver, British Columbia, Canada, Nov-Dec, 2015. Read More
  206. 133. How proactive is the spouse support in diabetes care?. Kesavadev J, Saboo B, Shankar A, Krishnan G, Jothydev S. IDF Congress, Vancouver, British Columbia, Canada, Nov-Dec, 2015. Read More
  207. 132. Unity in diversity: Religious festivals and its impact on diabetes in India. Kesavadev J, Shankar A, Ajai A, Krishnan G, Jothydev S, David A, Sadikot S. IDF Congress, Vancouver, British Columbia, Canada, Nov-Dec, 2015. Read More
  208. 131. Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy. Kesavadev J, Saboo B, Shankar A, Krishnan G, Jothydev S. Indian J Endocrinol Metab. Nov- Dec 2015. 19(6). 764–769. Read More
  209. 130. The bittersweet aroma of inhaled insulin. Invited lecture - Dr. Jothydev Kesavadev. Annual Meeting of Research Society for the Study of Diabetes in India, Lucknow. Oct- Nov 2015.
  210. 129. Role of Counselling In Ensuring Drug Compliance In Diabetes. Invited lecture - Mrs. Sunitha Jothydev. Annual Meeting of Research Society for the Study of Diabetes in India, Lucknow. Oct- Nov 2015.
  211. 128. Normalising vitamin D levels correlates with better glycaemic control: an observational study in a cohort in Kerala. Invited lecture - Dr. Arun Shankar. Annual Meeting of Research Society for the Study of Diabetes in India, Lucknow. Oct- Nov 2015.
  212. 127. A head to head comparison of two popular CGM devices in India - iPro2 vs. FreeStyle Libre Pro. - Abstract. 43rd Annual Conference of Research Society for the Study of Diabetes in India, Lucknow, 30 Oct-1 Nov, 2015.
  213. 126. How the emerging technologies in diabetes can help reduce the long term cost and complications in diabetes. Invited lecture: Dr.Jothydev Kesavadev. October 2-4, 2015: Uttarakhand Convocation Oration. Read More
  214. 125. Consensus Statement on Management of Post-Prandial Hyperglycemia in Clinical Practice in India. Aravind S, Saboo B, Sadikot S, Shah S.N, Makkar B, Kalra S, Kannampilly J, Kesavadev J, Ghoshal S, Zargar A, Nigam A, Hazra D, Tripathi K, Dharmalingam M, Shah P, Gandhi P, Sahay R, Unnikrishnan R, Gupta S, Bajaj S, Mukhopadhyay S, Kale S. J Assoc Physicians India. 2015 Aug;63(8):45-58. PMID: 27604435. Read More
  215. 124. Fasting in Ramadan with an insulin pump. Kesavadev J. J Pak Med Assoc. 2015. 65(5S1). S47-50. Read More
  216. 123. Utilization of Biosimilar insulin in Asian patients with diabetes - The Joint Asia Diabetes Evaluation (JADE) program. Gani L. U, Lau E, Luk A, Sobrepena L, Tran Q. K, Kesavadev J, Jia W, Chan J. C. N. Diabete Jun 2015, 64 (Supplement 1) P1023; DOI: 10.2337/db15- P1023. Link 1 | Link 2
  217. 122. Exploring and resolving the impact of food on post prandial glycemic excursions in a rice-eating population in S. India. Kesavadev J, Shankar A, Sanal G, Ajai N. A, Krishnan G,Jothydev S. Diabetes Jun 2015, 64 (Supplement 1) A623-A635; DOI: 10.2337/db15- A623-A635. 2486-PO. Link 1 | Link 2 |
  218. 121. Periodic CGM in T2DM: exploring benefits across various therapy choices. Kesavadev J, Pillai P. B. S, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Diabetes 2015 Jun, 64 (Supplement 1) P964; DOI: 10.2337/db15- P964. Link 1 | Link 2
  219. 120. Insulin-sparing effect of and Severe Hypoglycemia with Sitagliptin vs. Glimepiride. Kesavadev J, Pillai P. B. S, Shankar A, Krishnan G, Jothydev S. Diabetes Jun 2015, 64 (Supplement 1) PO2486; DOI: 10.2337/db15- PO2486. Read More
  220. 119. Comparing two models of diabetes care comprehensive education and telemonitoring vs. limited care. Kesavadev J, Vitale R, Babu P, Pillai S, Krishnan G, Jothydev S. Diabetes Jun 2015, 64 (Supplement 1) P743; DOI: 10.2337/db15- P743. Link 1 | Link 2
  221. 118. Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015. Tandon N, Kalra S, Balhara Y.P, Baruah M.P, Chadha M, Chandalia H.B, Chowdhury S,Kesavadev J, Kumar PK, V M.S, Mithal A, Modi S, Pitale S, Sahay R, Shukla R, Sundaram A, Unnikrishnan A.G, Wangnoo S.K. Indian J Endocrinol Metab. May-Jun 2015;19(3):317-31. PMID: 25932385; PMCID: PMC4366768. Read More
  222. 117. Insulin Pumps for Life vs Insulin Pumps for Luxury - The Indian Experience In Type 2 Diabetes. Kesavadev J, Saboo B, Babu P, Shankar A, Lally J, Sanal G, Krishnan G, Jothydev S. Read More
  223. 116. Available and evolving technologies and how they can be effectively utilised to bring down the exhaustive cost of diabetes care. Invited lecture: Dr.JothydevKesavadev. Diabetes: Preventing the Preventables Convention, Hong Kong ,May 23, 2015. Read More
  224. 115. Efficacy and safety of liraglutide therapy in 195 Indian patients with type 2 diabetes in real world setting. Kesavadev J, Shankar A, Gopalakrishnan G, Jothydev S.Diabetes Metab Syndr. May 2015. 9(1). 30-33. Read More
  225. 114. Intensifying Insulin Therapy in Type 2 Diabetes: Choices & Challenges Kumar A, Kesavadev J, Sethi B, Jain S. M, Guruprasad C. S, Shah S. N. J Assoc Physicians India. May 2015. 63(5S). 8-14. Review. Read More
  226. 113. The Bittersweet Aroma of Inhaled Insulin. Kesavadev J. Chapter 18. RSSDI Annual Conference Update 2015.
  227. 112. Use of Insulin Pump in Type 1 Diabetes Mellitus. Kesavadev J. Chapter 18. Clinical Case Series in Diabetes. Jaypee Brothers Medical Publishers 2015.
  228. 111. Will the Technological Advances in Devices Have Place in Diabetes Management in India? Kesavadev J. Micro labs Ltd. 2015.
  229. 110. Understanding Glycemic Variability & Glycemic Profile with Ambulatory Glucose Profile. Invited lecture - Dr.Jothydev Kesavadev. World Congress of Diabetes India, Chennai. Apr 2015.
  230. 109. Clinical Significance of CGM: Adopting and Adjusting Therapies. Invited lecture - Dr.Jothydev Kesavadev. World Congress of Diabetes India, Chennai. Apr 2015.
  231. 108. Long Term Consequences of Alternate Therapies for Diabetes - Myths vs. Realities. Invited lecture - Dr.Jothydev Kesavadev. World Congress of Diabetes India, Chennai. Apr 2015.
  232. 107. What are the points to be highlighted by a Diabetologist in a clinic to educator and dietitian. Invited lecture - Dr.Arun Shankar. World Congress of Diabetes India, Chennai. Apr 2015.
  233. 106. The Elderly Living Alone with Diabetes. Invited lecture - Mrs.Sunitha Jothydev. World Congress of Diabetes India, Chennai. Apr 2015.
  234. 105. Newer Insulins and GLP-1 RAs: How to position in Clinical Practice. Invited lecture: Dr.Jothydev Kesavadev. March 1, 2015: Gold Medal Oration: KMC Manipal. Read More
  235. 104. Role of Home Blood Pressure Monitoring in Halting the Progression of Diabetic Kidney Disease: 6 Year Follow up Data. Kesavadev J, Joshi S, Saboo B, Shankar A, Pillai P. S, Sanal G, Jothydev S. Diabetes Technol Ther. Feb 2015. 17. A123. Read More
  236. 103. Impact of Insulin Pump Therapy on Erectile Dysfunction in Type 2 Diabetes. Kesavadev J, Pillai P. S, Shankar A, Jothydev S. Diabetes Technol Ther. Feb 2015. 17. A40. Read More
  237. 102. The public health impact of unproven diabetes therapies and the role of education. Oral presentation - Dr Jothydev Kesavadev. 42nd Annual Meeting of Research Society for the Study of Diabetes in India, Bangalore, Nov 21-23, 2014.
  238. 101. Ensuring multi drug compliance in diabetes: role of hospital pharmacy. Oral presentation- Dr Arun Shankar. 42nd Annual Meeting of Research Society for the Study of Diabetes in India, Bangalore, Nov 21-23, 2014.
  239. 100. Insulin pumps in type 1 diabetes. Invited lecture - Dr Jothydev Kesavadev. 42nd Annual Meeting of Research Society for the Study of Diabetes in India, Bangalore, Nov 21-23, 2014.
  240. 99. Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment. Kesavadev J, Sadikot S. M, Saboo B, Shrestha D, Jawad F, Azad K, Wijesuriya M. A, Latt T. S, Kalra S. Indian J Endocrinol Metab. Sep-Oct 2014. 18(5). 600–607. Read More
  241. 98. Prevalence of undetected thyroid disorders in subjects with diabetes in South India: a cohort analysis. Krishnan G, Shankar A, Jothydev S, Kesavadev J. Diabetologia. Sep 2014;57 Suppl 1:1-564. Link 1 | Link 2
  242. 97. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice. Kesavadev J, Jain S.M, Muruganathan A, Das A.K; Diabetes Consensus Group. J Assoc Physicians India. Jul 2014 ;62(7 Suppl):34-41. Read More
  243. 96. Continuous Glucose Monitoring in 432 T2D Patients for Assessment of Safety and Cost effectiveness in Reaching A1C Targets. Kesavadev J, Shankar A, Lally J, Sanal G, Gopalakrishnan G, Jothydev S. Diabetes 2014 Jun, 63 (Supplement 1) P398; DOI: 10.2337/db14- P398. Link 1 | Link 2 | Link 3 | Link 4
  244. 95. Consensus guidelines for glycemic monitoring in type 1/type 2 and GDM. Kesavadev J, Sadikot S. M, Wangnoo S, Kannampilly J, Saboo B, Aravind S. R, Kalra S, Makkar B. M, Maji D, Saikia M, Anjana R. M, Rajput R, Singh S. K, Shah S, Dhruv U, Vishwanathan V. Diabetes Metab Syndr. May 2014. 8(3). 187-195. Read More | Request Full-text
  245. 94. Impact of new basal insulin on care in diabetes: a clinician's view. Invited lecture - Dr.Jothydev Kesavadev. Diabetes India Regional Update, Srinagar, Jammu & Kashmir. May, 2014.
  246. 93. Will Incretin Therapy delay Early Insulinization? - Debate - Dr.Jothydev Kesavadev and Dr.Narsingh Verma. Diabetes India Regional Update, Srinagar, Jammu & Kashmir. May, 2014.
  247. 92. Insulin Pumps: Where are we and what is the future? Invited lecture - Dr.Jothydev Kesavadev. Diabetes India Regional Update, Srinagar, Jammu & Kashmir. May, 2014.
  248. 91. Use of Insulin Pumps in T2DM in India: Merits and Demerits learnt over a decade. Invited Speaker. Advanced Technologies and Treatments for Diabetes (ATTD), Vienna, Austria 2014. O-86. Diabetes Technol Ther. Feb 2014. 16(S1): A-1-A-162. Read More
  249. 90. Clinical utility of cgm in pre-diabetes and its impact on modifying lifestyles. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Diabetes Technol Ther. 2014. 16. A41. P-106. Diabetes Technol Ther. Feb 2014; 16(S1): A-1-A-162. Link 1 | Link 2
  250. 89. Live brief weekly educational questionnaire via DTMS® as a tool to improve the acceptability and outcome in type 2 diabetes. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Diabetes Technol Ther. Feb 2014. 16(S1). A115-A116. P- 295. Read More
  251. 88. Use of Ipro2 in Real-Life Management of Type 2 Diabetes Patients In India. Mohan V, Kesavadev J, Jain S. M, Chawla M, Mutha A, Saboo B, Kovil R, Viswanathan V, Mithal A Punatar D, Shaikh, S, Shin J. P-311. Diabetes Technol Ther. Feb 2014. 16(S1): A-1-A-162. Read More
  252. 87. Insulin Pump in Type 2 diabetes mellitus. Kesavadev J. Jaypee Brothers Medical Publishers (P) Ltd.Page 120-133 World Clinics Diabetology Type 2 diabetes mellitus.World Clin Diabetol.2014;1(1):120-33.
  253. 86. Clinical Benefits of Liraglutide: Taking Therapy into the Real World. Kesavadev J. API Medicine Update Vol. 24: 2014.
  254. 85. Insulin pumps in Type 1 diabetes. Kesavadev J. RSSDI Annual Conference Update 2014.
  255. 84. Immunization in Diabetes. Kesavadev J. Diabetes Suraksha. Macmillan Medical Publishers 2014.
  256. 83. Understanding the safety of the new ultra long acting basal insulin. Ramachandran A, Gupta V, Kesavadev J, Kalra S. J Assoc Physicians India. Jan 2014;62(1 Suppl):35-42. PMID: 25330630. Read More
  257. 82. Safety of pneumococcal and influenza vaccination in diabetes patients in South India. Kesavadev J, Shankar A, Krishnan G, Jothydev S. IDF Congress, Melbourne, Australia, Dec, 2013. Read More
  258. 81. The young Indian female with type 1 diabetes: challenges with marriage. OP-0294 Oral Presentation: Dr.Jothydev Kesavadev. International Diabetes Federation (IDF) Congress, Melbourne, Australia, 2-6 Dec, 2013.
  259. 80. Continuous customized education via telemedicine: outcome data of events over 8 years. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. IDF Congress, Melbourne, Australia, Dec, 2013. Read More
  260. 79. High prevalence of undetected elevated blood pressure in Kerala population: Diabscreen Kerala 22. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. IDF Congress, Melbourne, Australia, Dec, 2013. Read More
  261. 78. Addendum: First injection technique recommendations for patients with diabetes, Forum for Injection Techniques India. Kalra S, Balhara Y. P. S, Baruah M. P, Chadha M, Chandalia H. B, Chowdhury S, Kesavadev J, Kumar K. M. P, Modi S, Pitale S, Rishi S, Sahay R, Sundaram A, Unnikrishnan A. G, Wangnoo S. K. Indian J Endocrinol Metab. Nov-Dec 2013. 17(6). 1005–1008. Read More
  262. 77. Insulin Pumps - Indian Context. Invited lecture - Dr Jothydev Kesavadev. 41st Annual Meeting of Research Society for the study of Diabetes in India, Delhi. Nov 2013.
  263. 76. Safety and Efficacy of Protaminated aspart Integrated with Telemedicine in Reducing A1c. Invited lecture - Dr. Arun Shankar. 41st Annual Meeting of Research Society for the study of Diabetes in India, Delhi. Nov 2013.
  264. 75. Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A1chieve study. Kesavadev J. Indian J Endocrinol Metab. Nov 2013. 17(S2). S565–S568. Read More
  265. 74. Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes. Meneghini L, Kesavadev J, Demissie M, Nazeri A, Hollander P. Diabetes, obesity and metabolism. 2013.15(8): 729-736. | Request Full-text
  266. 73. C-peptide levels not affected by duration of diabetes in a telemedicine based long-term follow up programme. Krishnan G, Pillai P. S, Shankar A, Jothydev S, Kesavadev J. Diabetologia. Sep 2013;56 Suppl 1:1-566. Link 1 | Link 2 | Link 3
  267. 72. Barriers and solutions to diabetes management: An Indian perspective. Wangnoo S. K, Maji D, Das A. K, Rao P. V, Moses A, Sethi B, Unnikrishnan A. G, Kalra S, Bantwal V. B. G, Kesavadev J, Jain S. M, Dharmalingam M. Indian J Endocrinol Metab. Jul-Aug 2013. 17(4). 594–601. Read More
  268. 71. Time of Insulin Initiation, Duration of disease and onset of Erectile Dysfunction in Indian men with T2D. Shankar A, Jothydev S, Gopalakrishnan G, Lally J, Kesavadev J. Diabetes Jun 2013, 62 (Supplement 1) PO2737; DOI: 10.2337/db13- PO2737. Link 1 | Link 2
  269. 70. Long Term Impact of Initial Insulin Therapy in New Onset T2D: 5 year Retrospective Data. Kesavadev J, Shankar A, Gopalakrishnan G, Jothydev S.Diabetes Jun 2013, 62 (Supplement 1) PO2552; DOI: 10.2337/db13- PO2552. Link 1 | Link 2
  270. 69. Superiority of a Telemedicine Based Counselling in Ensuring Multi Drug Compliance in T2D. Kesavadev J, Shankar A, Gopalakrishnan G, Lally J, Sanal G, Jothydev S. Diabetes Jun 2013, 62 (Supplement 1) 698-P; DOI: 10.2337/db13- 698-P. Link 1 | Link 2 | Link 3
  271. 68. Normal Vitamin D Levels Correlates with Lower HbA1c: A Cross Sectional Study Among 1270 Type 2 Diabetes Patients in South India. Gopalakrishnan G, Pillai P. B. S, Shankar A, Jothydev S, Kesavadev J. Diabetes 2013 Jun, 62 (Supplement 1) PO2763; DOI: 10.2337/db13- PO2763. Link 1 | Link 2
  272. 67. Role of Telemedicine in treating diabetes. Invited lecture - Dr.Jothydev Kesavadev. World Congress of Diabetes India, Kochi. Apr 2013.
  273. 66. Use of Insulin Pumps in India. Invited lecture - Dr.Jothydev Kesavadev. World Congress of Diabetes India, Kochi. Apr 2013. Read More
  274. 65. Psychological Aspects of Diabetes Management. Invited lecture - Mrs.Sunitha Jothydev. World Congress of Diabetes India, Kochi. Apr 2013.
  275. 64. Real Time Continuous Glucose Monitoring Vs Blinded CGM - Exploring Merits and Demerits in Clinical Practice. Invited lecture - Dr.Arun Shankar. World Congress of Diabetes India, Kochi. Apr 2013.
  276. 63. Attitudes and Behaviour Of Type 2 Diabetes Patients on Insulin Pumps. Kesavadev J, Shankar A, Krishnan G, Jothydev S. Diabetes Technol Ther. 2013 Feb. 15(S1). A43- A44. Link 1 | Link 2 | Link 3
  277. 62. Glycemic Variability in Type 2 Diabetes Correlates with Total Daily Dose of Insulin And Use of Sulfonylureas. Kesavadev J, Pillai P. B. S, Shankar A, Krishnan G, Jothydev S.Diabetes Technol Ther. 2013 Feb. 15(S1). A-66. Link 1 | Link 2 | Link 3
  278. 61. Improvement of glycemic control with addition of insulin detemir to existing antidiabetic therapy: a sub-group analysis of A1chieve observational study. Kesavadev J, Joshi S. R. J Assoc Physicians India. Jan 2013. 61(S1). 28-30. Read More
  279. 60. Continuous Glucose Monitoring System. Kesavadev J. Chapter 41, RSSDI Textbook of Diabetes 2013.
  280. 59. Various Emerging Techniques in Insulin Delivery Systems. Innovative Approaches in Type 2 diabetes. Kesavadev J. Chapter 42. Page 398-408. Micro labs Ltd.
  281. 58. Very Low Protein Diet with Ketoanalogue Supplementation in Diabetic Kidney Disease: Case Studies. Dietary Protein Restriction in Chronic Kidney Disease. Kesavadev J. Page 35-44 Published by Elsevier India Pvt.Ld.
  282. 57. Suggested use of vaccines in diabetes. Kesavadev J, Misra A, Das A. K, Saboo B, Basu D, Thomas N, Joshi S. R, Unnikrishnan A. G, Shankar A, Krishnan G, Unnikrishnan R, Mohan V.Indian J Endocrinol Metab. Nov 2012. 16(6). 886–893. Read More
  283. 56. Optimal statin dosages and compliance: a five year retrospective cohort analysis in South Indian type 2 diabetes subjects. Krishnan G, Pillai P. S, Shankar A, Kesavadev J, Jothydev S Diabetologia. Oct 2012;55 Suppl 1:S7-537. Link 1 | Link 2 | Link 3
  284. 55. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus - a retrospective study. Kesavadev J, Shankar A, Pillai P. B. S, Krishnan G, Jothydev S. Diabetes Technol Ther. Sep 2012. 14(9). 772-776. Link 1 | Link 2
  285. 54. High Bed Time Glucose and Early Morning Low Sugars in Elderly Subjects with Type 2 Diabetes (T2DM): An Incidental Finding with Clinical Significance. Kesavadev J, Shankar A, Lally J, Sanal G, Gopalakrishnan G, Jothydev S. Diabetes Jun 2012, 61 (Supplement 1) 881-P; DOI: 10.2337/db12- 881-P. Link 1 | Link 2
  286. 53. Patterns of Glycemic variability (GV) in Indian Type 2 diabetes (T2DM) patients on Insulin and Oral Hypoglycemic Agents (OHAs) and its Correlation with A1c and Hypoglycemia. Kesavadev J, Pillai P. B. S, Shankar A, Sanal G, Lally J, Gopalakrishnan G, Jothydev S.Diabetes Jun 2012, 61 (Supplement 1) 2343-PO; DOI: 10.2337/db12- 2343-PO. Read More
  287. 52. Efficacy and Safety of Liraglutide in 195 Patients with Type 2 Diabetes in India: A Retrospective Analysis. Kesavadev J, Shankar A, Gopalakrishnan G, Veeresh B, Jothydev S.Diabetes Jun 2012, 61 (Supplement 1) 2403-PO; DOI: 10.2337/db12- 2403-PO. Read More
  288. 51. Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting. Kesavadev J, Shankar A, Krishnan G, Jothydev S. Int J Gen Med. Apr 2012. 5. 317-322. Read More
  289. 50. Continuous Glucose Monitoring: Is it replacing SMBG in routine practice? Invited lecture - Dr Jothydev Kesavadev. Research Society for the Study of Diabetes in India, West Bengal Chapter 1st Annual Conference. March 2012.
  290. 49. CGM and pumps: Practical tips. Invited lecture - Dr Jothydev Kesavadev. Research Society for the Study of Diabetes in India, West Bengal, Annual Chapter- pre- conference workshop. Mar 2012.
  291. 48. Acceptance of Continuous Glucose Monitoring (CGM) as a Routine Investigation in Diabetes. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Lally J, Sanal G, Jothydev S.Diabetes Technol Ther. Feb 2012. 14(19). Read More
  292. 47. Geographical location and effectiveness of a simple telemedicine program (DTMS®) in diabetes. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Lally J, Jothydev S. Diabetes Technol Ther. Feb 2012. 14(19). Read More
  293. 46. Tele-medicine via DTMS® is cost-effective and satisfactory: still why it fails in minority with T2DM?. Kesavadev J, Pillai P. B. S, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S.O-0427.IDF Congress, Dubai, UAE, Dec 2011.
  294. 45. Acceptability of a home delivered assessment of lab & vital signs in Diabetes mellitus & its role in treatment motivation. Kesavadev J, PillaiP. B. S, ShankarA, SanalG, KrishnanG, JothydevS.P-1798. IDF Congress, Dubai, UAE, Dec 2011. Read More
  295. 44. Effectiveness of Liraglutide in Routine Clinical Practice: Six Months Follow-Up Data from India. Ghosal S, Kesavadev J, Kalra S.P-1852. IDF Congress, Dubai, UAE, Dec 2011. Read More
  296. 43. Pump Technology: Basics. Insulin Pump use in India. Invited lecture - Dr Jothydev Kesavadev. Annual conference of Research Society for the Study of Diabetes in India, Mumbai. Nov 2011.
  297. 42. An Asian Indian woman with Wolfram syndrome on insulin pump: successful pregnancy and beyond. Kesavadev J, Kumar A, Shankar A, Gopalakrishnan G, Permutt M. A, Wasson J, Jothydev S. Diabetes Technol Ther. Jul 2011. 13(7). 781-785. Read More
  298. 41. A1c, BP and LDL Goals - Successful Use of Telemedicine (DTMS®) in 1000 Compliant T2DM Subjects over 6 Months. Kesavadev J, Babu P, Pillai S, Shankar A, Dinkar G, Lally J, Sanal G, Gopalakrishnan G, Jothydev S.Diabetes Jun 2011, 60 (Supplement 1) 229- OR; DOI: 10.2337/db11- 229- OR. Link 1 | Link 2
  299. 40. Significance of Screening for Thyroid Disorders in Type 2 Diabetes. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Jothydev S. Diabetes Jun 2011, 60 (Supplement 1) P1377; DOI: 10.2337/db11- P1377. Link 1 | Link 2
  300. 39. Utility of CGM over Conventional SMBG in Making Treatment Changes in Insulin Requiring T2DM Patients. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Sanal G, Lally J, Jothydev S.Diabetes Jun 2011, 60 (Supplement 1) 912 P; DOI: 10.2337/db11- 912 P. Link 1 | Link 2
  301. 38. Change in Antihypertensive Medication Dose Following Initiation of Liraglutide in Patients. Kesavadev J, Shankar A, Gopalakrishnan G, Jothydev S. Diabetes Jun 2011, 60 (Supplement 1) 2357-PO; DOI: 10.2337/db11- 2357-PO. Link 1 | Link 2
  302. 37. Continuous insulin infusion systems in type 2 diabetes. Kesavadev J. J Assoc Physicians India. 2011 Apr. 59(S). 41-43 Read More
  303. 36. CGM as a tool For Therapeutic Decision Making (TDM) In Type 2 Diabetes Mellitus. Kesavadev J, Babu P, Gopalakrishnan G,Jothydev S. P-108. Feb 2011. Read More
  304. 35. Pregnancy, Wolfram Syndrome and Insulin Pump: benefits beyond glycemic control. Kesavadev J, Kumar A, Shankar A, Gopalakrishnan G, Jothydev S.P-109. Feb 2011. Read More
  305. 34. Insulin Pumps in India: the success story: untold. Invited lecture - Dr Jothydev Kesavadev. 38th Annual Meeting of Research Society for the Study of Diabetes in India, 22-25 Nov, 2010.
  306. 33. Cost effectiveness of a tele follow up program for diabetes across 5years. PO. 38th Annual Meeting of Research Society for the Study of Diabetes in India, 22-25 Nov, 2010.
  307. 32. Literate Kerala population and reluctance to continue Statins: DIABSCREEN KERALA, 15- PO. 38th Annual Meeting of Research Society for the Study of Diabetes in India, 22-25 Nov, 2010.
  308. 31. Refractory Neuropathic Pain and Erectile Dysfunction - Is CSII a Viable? - PO 38th Annual Meeting of Research Society for the Study of Diabetes in India, 22-25 Nov, 2010.
  309. 30. Telefollow up and SMBG Via "DTMS"- A Cost Effective Tool for A1c Lowering. Kesavadev J, Shankar A, Shamsudeen J, Dinkar G, Pillai B. S, Gopalakrishnan G, Ajai N, Sathish J, Jothydev S. Diabetes Jun 2010, 59 (Supplement 1) 2083-PO; DOI: 10.2337/db10- 2083-PO. https://professional.diabetes.org/abstract/telefollow-and-smbg-quotdtmsquot-ndash-cost-effective-tool-a1c-lowering
  310. 29. High Prevalence of Elevated Transaminases among T2DM in S.India. Kesavadev J, Shankar A, Pillai P. B. S, Suresh P, Gopalakrishnan G, Jothydev S. Diabetes Jun 2010, 59 (Supplement 1) 2340-PO; DOI: 10.2337/db10- 2340-PO. Read More
  311. 28. Cost-Effectiveness of Education Via "DTMSTM" and Achievement of Goals: Evidence Over a Decade. Oral Presentation - Speaker: Dr.Jothydev Kesavadev, June, 2010.
  312. 27. Advanced Pump Training in Type 2 Diabetes: Pros & Cons. Oral Presentation, Speaker: Gopika Krishnan. American Diabetes Association, 70th Scientific Sessions, Orlando, June 25-29, 2010.
  313. 26. A Clinician’s Perspective on Liraglutide in Clinical Practice. Tandon N, John M, Sharma S. K, Kesavadev J, Ganapathy B. J Assoc Physicians India, 2010. 58. 29-30. Read More
  314. 25. Use of Insulin Pumps in India: Suggested Guidelines Based on Experience and Cultural Differences. Kesavadev J, Das A.K, Unnikrishnan R, Joshi S. R, Ramachandran A, Shamsudeen J, Krishnan G, Jothydev S, Mohan V. Diabetes Technol Ther. 2010. 12(10). 823–831. Read More
  315. 24. Insulins in Continuous Subcutaneous Insulin Infusion. Kesavadev J. Asian Journal of Diabetology, April-June 2010.
  316. 23. Newer Insulin and Insulin pumps. Kesavadev J. The Journal of the Association of Physicians of India (Tamil Nadu Chapter) (TAPIJ), May-Aug 2010
  317. 22. Significant Alleviation of Neuropathic Pain with Insulin Pumps (CSII) in T2DM subjects previously on MDI. Kesavadev J, Shamsudeen J, Shankar A, Gopalakrishnan G, Satheesh J, Jothydev S. Feb 2010. Read More
  318. 21. Insulin Pump Workshop. Invited lecture - Dr Jothydev Kesavadev. 37th Annual Meeting of Research Society for the Study of Diabetes in India. Ahmedabad, Gujarat. Nov 2009.
  319. 20. Good Nutrition: Avoidance of excess weight with Pumps. Invited Speaker: Dr.Jothydev Kesavadev. IDF Congress, Montreal, Canada, Oct, 2009.
  320. 19. Diabetes and Discrimination: Home and Siblings. Invited Speaker: Mrs.Sunitha Jothydev. IDF Congress, Montreal, Canada, Oct, 2009.
  321. 18. Low compliance of Statins in Kerala Rural Population (Diabscreen 14). Kesavadev J, Shamsudeen J, Dinkar G, Jothydev S, Shankar A.PO. IDF Congress, Montreal, Canada, Oct, 2009. Read More
  322. 17. Successful outcome of a multidisciplinary team over an individual approach in imparting diabetes education. Kesavadev J, Shamsudeen J, Dinkar G, Jothydev S, Shankar A. PO. IDF Congress, Montreal, Canada, Oct, 2009.
  323. 16. Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes. Kesavadev J, Balakrishnan S, Ahammed S, Jothydev S. Diabetes Technol Ther. 2009. 11(8). 517-521. Read More
  324. 15. Role of Continuous Glucose Monitoring in Modifying Diet and Lifestyles in Diabetes subjects. Kesavadev J, Shamsudeen J, Badarudeen S, Jothydev S, Dinkar G. Oral Presentation, Speaker: Dr.JothydevKesavadev. Diabetes Jun 2009, 58 (Supplement 1) 268-OR; DOI: 10.2337/db09- 268-OR. Read More
  325. 14. Requirement of High Dosage of Insulin in Previous Users of Glibenclamide with Uncontrolled Diabetes. Kesavadev J, Shamsudeen J, Badarudeen S, Simon N. A, Jothydev S. Diabetes Jun 2009, 58 (Supplement 1) PO2079; DOI: 10.2337/db09- PO2079. Read More
  326. 13. Indian Patients with Diabetes Experienced Better Glycemic Control, Less Weight Gain and Hypoglycaemia with Insulin Detemir When Switched from NPH and Insulin Glargine in PREDICTIVE® Study. Kesavadev J, Singh P, Pitle S. U, Bhattacharyya A, Mayya R, Moharana A. K, Pathak A, Kalra S. Diabetes Jun 2009, 58 (Supplement 1) PO2053; DOI: 10.2337/db09- PO2053. Read More
  327. 12. Reasons for non-compliance to Diabetes Tele Medicine Based Follow up Program in Type 2 Diabetes. ATTD, 2nd International Conference, Greece, Athens, Feb 25-28, 2009.
  328. 11. Insulin Pump in 56 Type 2 diabetes subjects: Improvement of sexual satisfaction and neuropathic symptoms. ATTD, 2nd International Conference, Greece, Athens, Feb 25-28, 2009.
  329. 10. Serious symptomatic hypoglycemia in a patient on insulin pump. Kesavadev J, Shankar A, Jothydev S- Presented by Dr. Arun Shankar. 36th Annual Meeting of Research Society for the Study of Diabetes in India, Hyderabad, 21-23 Nov, 2008
  330. 9. Experiences with Insulin Pump in 52 Patients with Type 2 Diabetes in India. Kesavadev J, Kumar A, Ahammed S, Jothydev S.Diabetes Jun 2008, 57 (Supplement 1). Read More
  331. 8. Insulin Aspart Induced Lipoatrophy in a Patient on Insulin Pump. Kesavadev J, Kumar A, Ahammed S, Dinkar G, Jothydev S. Diabetes Jun 2008, 57 (Supplement 1) PO2093; DOI: 10.2337/db08- PO2093. Read More
  332. 7. High Prevalence of Dyslipidemia and Hypertension Detected in a Screening Program for Diabetes in a Rural population of a Southern State in India, Kerala. Kumar A, Kesavadev J, Ahammed S, Dinkar G, Jothydev S.Diabetes Jun 2008, 57 (Supplement 1) 2424-PO; DOI: 10.2337/db08- 2424-PO. Read More
  333. 6. A Study on the Effects of Acarbose in Reducing Post-Prandial Blood Glucose and Achieving HbA1c. Ahammed S, Kumar A, Gopi D. K, Kesavadev J. Diabetes Jun 2008, 57 (Supplement 1) 438-P; DOI: 10.2337/db08- 438-P. Link 1 | Link 2
  334. 5. Insulin pumps, Indian Perspective and troubleshooting. Invited lecture: Dr.Jothydev Kesavadev. 35th Annual Meeting of the Research Society for the Study of Diabetes in India, Kolkata. Nov 2007.
  335. 4. Insulin Pumps: Global Perspective. Invited lecture: Dr.Jothydev Kesavadev. 35th Annual Meeting of the Research Society for the Study of Diabetes in India, Kolkata. Nov 2007.
  336. 3. Achieving Desirable Glycemic Targets without the risks of Hypoglycemia using a Teletitration program. Kesavadev J, Rasheed S. A, Nair D. R. Diabetes Jun 2007, 56 (Supplement 1) 0421-P; DOI: 10.2337/db07- 0421-P. Link 1 | Link 2
  337. 2. Dramatic Response of Painful Peripheral Neuropathy with Insulin Pump in Type 2 Diabetes. Kesavadev J, Rasheed S. A.Diabetes Jun 2007, 56 (Supplement 1) 2097-PO; DOI: 10.2337/db07- 2097-PO. Read More
  338. 1. Diabetes in old age: an emerging epidemic. Kesavadev J, Short K.R, Nair K.S. J Assoc Physicians India. 2003 Nov;51:1083-94. Read More
 

Contact Us

Trivandrum

Jothydev's Diabetes & Research Centre, JDC Junction, Mudavanmugal, Konkalam, Trivandrum, Kerala, India.
Pin-695032

Kochi

Jothydev's Diabetes Research Centre & Hospitals Pvt Ltd,
Ist Floor, Thekkekkara Comercial Centre, Civil Lines Road, Padivattom, Edapally PO, Kochi, Kerala, India.
Pin - 682024

Attingal

Jothydev's Diabetes Hospital & Research Centre,
CSI Mission Hospital Campus, Attingal, Trivandrum, Kerala, India. Pin-695101.

 

+91-9495346200
+91-9496246200

info@jothydev.net

advice@jothydev.net

toll free number : 1800-425-40055